4//SEC Filing
Trapp Todd A 4
Accession 0001415889-22-011061
CIK 0000815094other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:48 PM ET
Size
19.4 KB
Accession
0001415889-22-011061
Insider Transaction Report
Form 4
ABIOMED INCNASD
Trapp Todd A
Vice President, CFO
Transactions
- Sale
Common Stock, $0.01 par value
2022-11-01$378.64/sh−479$181,368→ 16,185 total - Sale
Common Stock, $0.01 par value
2022-11-01$377.82/sh−263$99,367→ 16,664 total - Sale
Common Stock, $0.01 par value
2022-11-01$379.35/sh−191$72,456→ 15,994 total - Sale
Common Stock, $0.01 par value
2022-11-01$380.20/sh−67$25,473→ 15,927 total
Holdings
- 3,737
Stock Option (Right to Buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying) - 7,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 6,530
Stock Option (Right to Buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
Footnotes (7)
- [F1]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F2]This price represents the sale price of the transactions on the reported date at $377.8200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F3]This price represents the sale price of the transactions on the reported date at $378.6378. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F4]This price represents the sale price of the transactions on the reported date at $379.3497. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F5]This price represents the sale price of the transactions on the reported date at $380.1973. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F6]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F7]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001638242
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:48 PM ET
- Size
- 19.4 KB